Details for Belgium Supplementary Protection Certificate: 2017C/054
✉ Email this page to a colleague
Belgium Supplementary Protection Certificate: 2017C/054
Country | Patent Number | Supplementary Protection Certificate | SPC Country | SPC Description | SPC Expiration |
---|---|---|---|---|---|
European Patent Office | 2041177 | 2017C/054 | Belgium | PRODUCT NAME: KEVZARA - SARILUMAB; AUTHORISATION NUMBER AND DATE: EU/1/17/1196 20170627 | ⤷ Try a Trial |
>Country | >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Description | >SPC Expiration |